AGP

Welcome to the Brand page for “AGP”, which is offered here for Providing temporary use of a suite of non-downloadable computer software applications for grouping and categorizing human genes according to their biological function, analyzing the role of genes in promoting or inhibiting disease activity associated with autoimmune diseases, cardiovascular disease, inflammatory diseases, neurological diseases, infectious diseases and oncological diseases and scoring such genes based on their role in promoting or inhibiting such disease activity, identifying blood and non-blood cells within the gene sequences contained in human tissues and organs, and analyzing genes and genetic profiles to assess disease activity in patients suffering from autoimmune diseases, cardiovascular disease, inflammatory diseases, neurological diseases, infectious diseases and oncological diseases, and assessing the efficacy of pharmaceuticals, drug therapies and treatments to treat such diseases, all of the foregoing excluding any analysis, assessments or interpretations relating to glucose levels or glucose data;.

Its status is currently believed to be active. Its class is unavailable. “AGP” is believed to be currently owned by “Ampel, LLC”.